BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8873695)

  • 1. Effects of benazepril and nicardipine on microalbuminuria in normotensive and hypertensive patients with diabetes.
    De Cesaris R; Ranieri G; Andriani A; Lamontanara G; Cavallo A; Bonfantino MV; Bertocchi F
    Clin Pharmacol Ther; 1996 Oct; 60(4):472-8. PubMed ID: 8873695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A; Amer W; Anwar E; Bashir K
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):429-35. PubMed ID: 19414946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.
    Marre M; Garcia Puig J; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Pozza G; Chastang C; Ollivier JP; Amouyel P; Asmar R
    J Hypertens Suppl; 2003 Mar; 21(1):S19-24. PubMed ID: 12769163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO; Jeffers BW; Gifford N; Schrier RW
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
    Bakris GL; Toto RD; McCullough PA
    J Hum Hypertens; 2005 Feb; 19(2):139-44. PubMed ID: 15457206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microalbuminuria in diabetics with moderate hypertension].
    Valensi P; Ferrière F; Attali JR; Erault C; Modigliani E; Delrieux C; Sebaoun J
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):785-9. PubMed ID: 3099693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with benazepril, a long-acting ACE inhibitor, in the management of diabetic hypertension].
    Winkler G; Hajós P; Pál B; Tóth J
    Orv Hetil; 1997 Jul; 138(27):1737-42. PubMed ID: 9273485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes.
    Puig JG; Marre M; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Gallois Y; Amouyel P; Ollivier JP; Asmar R
    Am J Hypertens; 2007 Jan; 20(1):90-7. PubMed ID: 17198918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function, glycaemic control and perindopril in diabetic patients.
    Brichard S; Ketelslegers JM; Lambert AE
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():57-61. PubMed ID: 2505714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial.
    Schrier RW; Estacio RO; Mehler PS; Hiatt WR
    Nat Clin Pract Nephrol; 2007 Aug; 3(8):428-38. PubMed ID: 17653121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of and tolerance to prolonged release prazosin in patients with hypertension and non-insulin dependent diabetes].
    Hanon O; Giacomino A; Troy S; Bernaud C; Girerd X; Weber S
    Ann Cardiol Angeiol (Paris); 2000 Oct; 49(7):390-6. PubMed ID: 12555491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of nicardipine in type 2 diabetic patients with slight hypertension.
    Faguer de Moustier B; Paoli V
    J Cardiovasc Pharmacol; 1990; 16 Suppl 2():S26-33. PubMed ID: 1369705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
    Kamoi K; Ikarashi T
    Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
    Weber MA; Bakris GL; Dahlöf B; Pitt B; Velazquez E; Gupte J; Lefkowitz M; Hester A; Shi V; Weir M; Kjeldsen S; Massie B; Nesbitt S; Ofili E; Jamerson K
    Blood Press; 2007; 16(1):13-9. PubMed ID: 17453747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.